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Abstract
Background: Older people living in nursing homes are at high risk of falling because of their
general frailty and multiple pathologies. Prediction of falls might lead to an efficient allocation of
preventive measures. Although several tools to assess the risk of falling have been developed, their
impact on clinically relevant endpoints has never been investigated. The present study will evaluate
the clinical efficacy and consequences of different fall risk assessment strategies.
Study design: Cluster-randomised controlled trial with nursing home clusters randomised either
to the use of a standard fall risk assessment tool alongside nurses' clinical judgement or to nurses'
clinical judgement alone. Standard care of all clusters will be optimised by structured education on
best evidence strategies to prevent falls and fall related injuries. 54 nursing home clusters including
1,080 residents will be recruited. Residents must be ≥ 70 years, not bedridden, and living in the
nursing home for more than three months. The primary endpoint is the number of participants with
at least one fall at 12 months. Secondary outcome measures are the number of falls, clinical
consequences including side effects of the two risk assessment strategies. Other measures are fall
related injuries, hospital admissions and consultations with a physician, and costs.
Background
Fall prevention in the elderly has been recognised as an
important area of research and intervention [1]. Numer-
ous studies have presented combinations of fall related
risk factors and a number of risk assessment tools have
been developed [2,3]. However, few of these tools are
based on rigorous research. The minority has been ade-
quately tested for accuracy [4]. Reproducibility and trans-
portability have been rarely investigated [5]. An own
recently conducted systematic review including 27 publi-
cations on 25 non-laboratory fall risk assessment tools
found that only 13 instruments have been validated in
different settings [6]. Treatment paradox has been dis-
cussed by only four publications although it seems to be
an important source of bias in accuracy studies which use
the number of fallers as reference standard. However,
there is no other measure to use as the gold standard for
determining the validity of a fall risk assessment tool.
Treatment paradox is difficult to overcome as it would be
unethical to discourage fall prevention measures in the
clinical setting in order to test risk assessment tools. None
of the publications included in the systematic review [6]
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ment like the application of physical restraints.
A German national nursing guideline on fall prevention
discourages the use of a risk assessment tool [7]. However,
as shown in a national survey these instruments are
increasingly used throughout different nursing settings
[8].
Only three tools have been repeatedly evaluated in geriat-
ric populations: the Tinetti Test, the Mobility Interaction
Fall Chart (MIF) and the Downton Index [9-11]. The
Tinetti Test [9] and the MIF [10] are not suitable for rou-
tine nursing assessment in nursing homes as they are
time-consuming and require special training whereas the
Downton Index has been described to be easily adminis-
tered by nurses [11]. Few accuracy studies compared fall
risk assessment tools to nurses' clinical judgement
[4,10,12,13]. Predictive values were unsatisfactory for
both risk assessment strategies. None of the tools was
superior to nurses' clinical judgement.
The impact of the use of a fall risk assessment tool on clin-
ically relevant endpoints has never been investigated
within a methodologically rigorous trial. Therefore, we
designed a randomised controlled trial to compare the
clinical efficacy and consequences of the use of a standard
fall risk assessment tool alongside nurses' clinical judge-
ment with nurses' clinical judgement alone. We chose the
Downton Index as comparator to single nurses' clinical
judgement since it has been validated in a nursing home
population and its predictive value is comparable to other
instruments. The Downton Index is easy to administer
and is comparable to those non-validated tools already in
use in German nursing homes.
Methods
Study design and setting
The study is a cluster-randomised controlled trial over 12
months with nursing homes randomised either to opti-
mised standard care and the use of the Downton Index or
optimised standard care alone. A full economic evalua-
tion is also being conducted.
Ethical considerations
The protocol has been approved by the ethics committee
of the Hamburg chamber of physicians and the regional
data protection office.
Study interventions
A structured single education session of 60 to 90 minutes
will be provided for all clusters to optimise standard care
and to minimise possible centre effects. The education
programme will cover information on best evidence strat-
egies to prevent falls and fall related injuries. The pro-
gramme is based on principles of social learning theory
[14]. The development of the curriculum followed
approaches we have successfully tested for other educa-
tion programmes [15,16].
After randomisation nurses of the intervention group (IG)
will be introduced to the use of the Downton Index. A
nominated nurse in charge of each cluster will then be
responsible for the monthly application of the tool. No
further intervention will be carried out in the control
group.
Identification of clusters and participants
Nursing homes in the cities Hamburg and possibly
Bremen, Germany, and respective catchment areas will be
invited to participate. A cluster is defined as a nursing
home by itself or an independently working ward of a
large nursing home. In a first step, a serially numbered list
of all residents of each cluster will be produced by the
nurse in charge. In a second step 20 residents fulfilling the
predefined inclusion criteria (≥ 70 years old, not bedrid-
den, and living in the nursing home for more than three
months) will be selected using investigators' random
table. Descriptive data on the cluster and participating res-
idents will be collected by the nurse in charge supported
by the external investigators. The figure shows the sum-
mary of the trial design.
Randomisation
We will use computer generated randomisation lists for
concealed allocation of clusters. To obviate disparate sam-
ple sizes permuted blocks will be used. Clusters will be
allocated by an external researcher immediately after col-
lection of baseline data and administration of the educa-
tion programme.
Clinical outcomes measures
The primary outcome is the number of participants with
at least one fall at 12 months. Secondary outcome meas-
ures are the number of falls, clinical consequences, i.e. fall
and injury prevention measures applied, and side effects
of the two risk assessment strategies. Side effects are
defined as the application of physical or pharmacological
restraints. Injuries and fractures related to falls, hospital
admissions and consultations with a physician related to
falls irrespective of the reason for falls, and costs will also
be recorded.
Nursing staff will have to fill in a specially developed doc-
umentation sheet in case of a fall event, also a documen-
tation sheet on measures used to prevent falls once a
month.
Data will be checked monthly during personal visits of the
investigators. It is not possible to objectify the docu-Page 2 of 4
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required to document falls in nursing homes. Interrater
reliability of the Downton Index will be determined in a
subgroup of nurses of the IG clusters.
Sample size calculation
It is assumed that about 45% of the participants in the
control group will experience at least one fall in 12
months with an intra-class correlation coefficient of ICCC
= 0.075. A cluster-randomisation with about 20 partici-
pants in each cluster leads to a variation inflation factor of
VIF = 2.425. Assuming that 20% of the participants will
not complete follow-up and furthermore assuming an
absolute difference of 15% (incidence of fallers in the
Downton Index-group: 30%) to reach a significant result
to the level of alpha = 0.05 with a power of 80% a total
sample size of n = 1,080 participants is needed. Therefore
the sample size comprises a total of 54 clusters with about
20 participants each.
Statistical analysis
The main outcome is the proportion of persons with at
least one fall and will be analysed by using a chi-square
test adjusted for cluster randomisation [17]. The effect of
the risk assessment tool will be expressed as relative risk,
difference in absolute risk, and number needed to treat.
For risk differences 95% confidence intervals will be cal-
culated using a method appropriate for cluster-ran-
domised trials [18]. For all other follow up data the cluster
will be used as unit of analysis. For statistical comparisons
between the groups the Wilcoxon rank sum test will be
performed. Two-sided p ≤ 0.05 will be regarded as signif-
icant. Interrater reliability will be calculated using kappa
statistics.
Economic evaluation
The economic evaluation will adopt the viewpoint of the
German health and nursing care insurance, adding up all
costs and savings relevant from the viewpoint of health
Summary of trial designFigure 1
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costs for optimisation of usual care for both groups, costs
for using the fall risk assessment tool in the IG as well as
medical and nursing care costs following falls for both
groups. Costs for the interventions will be estimated
based on information from trial records. The analysis will
adopt an incremental approach such that data collection
will concentrate on resource use differences between
study groups. The process of collecting data on resource
use will be undertaken separately from data collection on
unit costs. Resource use data due to fall related health care
will be collected by the investigators during the personal
visits using a cost component protocol. The documenta-
tion sheet has been successfully evaluated in a recent eco-
nomic evaluation of a randomised controlled trial [19].
Unit costs will be collected from different sources includ-
ing published data, health insurances, and various health
care providers.
At present, it is not possible to state with certainty which
form of economic analysis will be employed, since this
will be driven in part by the clinical study results. If a dif-
ference in the primary endpoint is observed, then a cost
efficacy analysis will be conducted. Otherwise a cost com-
parison analysis will be conducted. Since cost data will be
available for the duration of the trial only, the appropriate
effectiveness measure is the one that allows treatment
effects during the trial only. A sensitivity analysis on the
key variables that might influence the result of the eco-
nomic evaluation will be carried out.
Time plan
The pilot phase of the study started in September 2005.
Consecutive recruitment of clusters has started at the same
time and is expected to last 4 to 6 months.
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